169 related articles for article (PubMed ID: 421447)
1. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
Resnick RB; Schuyten-Resnick E; Washton AM
Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
[No Abstract] [Full Text] [Related]
2. Narcotic antagonists: naltrexone progress report: foreword.
Jaffe J
NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
[No Abstract] [Full Text] [Related]
3. Methadone maintenance and narcotic blocking drugs.
Wikler A
Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
[TBL] [Abstract][Full Text] [Related]
4. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
5. The clinical usefulness of narcotic antagonists: implications of behavioral research.
Meyer RE; Mirin SM; Altman JL
Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
[No Abstract] [Full Text] [Related]
6. Cyclazocine and methadone in narcotic addiction.
Freedman AM; Fink M; Sharoff R; Zaks A
JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
[No Abstract] [Full Text] [Related]
7. Toward a rational selection of treatment for addiction.
O'Brien CP
Curr Psychiatry Rep; 2007 Dec; 9(6):441-2. PubMed ID: 18221622
[No Abstract] [Full Text] [Related]
8. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
Martin WR
NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
[No Abstract] [Full Text] [Related]
9. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
Poser W; Ehrenreich H
Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
[No Abstract] [Full Text] [Related]
10. Cyclazocine treatment of opiate dependence: a progress report.
Resnick RB; Fink M; Freedman AM
Compr Psychiatry; 1971 Nov; 12(6):491-502. PubMed ID: 5117068
[No Abstract] [Full Text] [Related]
11. Effects of chronic treatment with methadone and naltrexone on sleep in addicts.
Staedt J; Wassmuth F; Stoppe G; Hajak G; Rodenbeck A; Poser W; Rüther E
Eur Arch Psychiatry Clin Neurosci; 1996; 246(6):305-9. PubMed ID: 8908412
[TBL] [Abstract][Full Text] [Related]
12. Blockade with methadone, cyclazocine, and naloxone.
Freedman AM; Zaks A; Resnick R; Fink M
Int J Addict; 1970 Sep; 5(3):507-15. PubMed ID: 5524385
[No Abstract] [Full Text] [Related]
13. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
Stimmel B
J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922
[No Abstract] [Full Text] [Related]
14. Regarding naltrexone for probationers and parolees.
Stancliff S
J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
[No Abstract] [Full Text] [Related]
15. [Detoxification in withdrawal state in methadone maintenance patients].
Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
[TBL] [Abstract][Full Text] [Related]
16. The use of drugs in the management of drug dependence.
Eddy NB
J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204
[No Abstract] [Full Text] [Related]
17. A behavioral paradigm for the evaluation of narcotic antagonists.
Meyer RE; Mirin SM; Altman JL; McNamee HB
Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of narcotic dependence.
Maykut MO
Prog Neuropsychopharmacol; 1977; 1(1-2):31-49. PubMed ID: 31641
[No Abstract] [Full Text] [Related]
19. NIDA's naltrexone research program.
Julius D
NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
[No Abstract] [Full Text] [Related]
20. Role of opioid antagonists in treating intravenous cocaine abuse.
Kosten TR; Kleber HD; Morgan C
Life Sci; 1989; 44(13):887-92. PubMed ID: 2927249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
